GSS.AX
Price:
$0.26
Market Cap:
$59.06M
Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. The company was incorporated in 2001 and is headquartered in ...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2015-03-30
Stock Exchange
ASX
Ticker
GSS.AX
According to Genetic Signatures Limited’s latest financial reports and current stock price. The company's current PE Ratio is -2.89. This represents a change of -13.76% compared to the average of -3.35 of the last 4 quarters.
The mean historical PE Ratio of Genetic Signatures Limited over the last ten years is -7.74. The current -2.89 PE Ratio has changed 3.63% with respect to the historical average. Over the past ten years (40 quarters), GSS.AX's PE Ratio was at its highest in in the June 2020 quarter at 294.82. The PE Ratio was at its lowest in in the June 2022 quarter at -25.32.
Average
-7.74
Median
-9.29
Minimum
-130.83
Maximum
89.08
Discovering the peaks and valleys of Genetic Signatures Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 266.76%
Maximum Annual PE Ratio = 89.08
Minimum Annual Increase = -168.09%
Minimum Annual PE Ratio = -130.83
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -4.12 | -41.47% |
| 2024 | -7.03 | 31.25% |
| 2023 | -5.36 | -109.91% |
| 2022 | 54.05 | -39.33% |
| 2021 | 89.08 | -168.09% |
| 2020 | -130.83 | 266.76% |
| 2019 | -35.67 | 208.95% |
| 2018 | -11.55 | -15.73% |
| 2017 | -13.70 | 11.29% |
| 2016 | -12.31 | 32.25% |
The current PE Ratio of Genetic Signatures Limited (GSS.AX) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.50
5-year avg
25.33
10-year avg
-7.74
Genetic Signatures Limited’s PE Ratio is greater than Cyclopharm Limited (-8.09), greater than ImpediMed Limited (-3.89), less than Cryosite Limited (30.11), greater than Amplia Therapeutics Limited (-6.86), greater than Mach7 Technologies Limited (-22.16), greater than Beamtree Holdings Limited (-9.83), greater than Compumedics Limited (-54.55), less than Medical Developments International Limited (616.65), greater than Cynata Therapeutics Limited (-6.25), greater than Micro-X Limited (-4.02),
| Company | PE Ratio | Market cap |
|---|---|---|
| -8.09 | $108.91M | |
| -3.89 | $75.38M | |
| 30.11 | $55.15M | |
| -6.86 | $64.13M | |
| -22.16 | $135.11M | |
| -9.83 | $61.03M | |
| -54.55 | $74.94M | |
| 616.65 | $59.15M | |
| -6.25 | $61.74M | |
| -4.02 | $58.77M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genetic Signatures Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genetic Signatures Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Genetic Signatures Limited's PE Ratio?
How is the PE Ratio calculated for Genetic Signatures Limited (GSS.AX)?
What is the highest PE Ratio for Genetic Signatures Limited (GSS.AX)?
What is the 3-year average PE Ratio for Genetic Signatures Limited (GSS.AX)?
What is the 5-year average PE Ratio for Genetic Signatures Limited (GSS.AX)?
How does the current PE Ratio for Genetic Signatures Limited (GSS.AX) compare to its historical average?